查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
一次性生物反應器的全球市場（第 3 版）- 按生物反應器類型、運營規模、細胞培養類型、合成生物製品類型、最終用戶和關鍵區域劃分的分佈：行業趨勢、預測（2023-2035）
市場調查報告書
商品編碼
1320993

一次性生物反應器的全球市場（第 3 版）- 按生物反應器類型、運營規模、細胞培養類型、合成生物製品類型、最終用戶和關鍵區域劃分的分佈：行業趨勢、預測（2023-2035）

Single Use Bioreactors Market (3rd Edition)-Distribution by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, End-users, Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035
出版日期: | 出版商: Roots Analysis | 英文 356 Pages | 商品交期: 最快1-2個工作天內

價格

受新型生物製藥需求不斷增長、精準醫療高采用率以及生物加工技術進步的推動，到 2023 年，全球一次性生物反應器市場規模預計約為 13 億美元。預計將以2023 年至2035年復合年增長率為17%。 目前，市場由提供攪拌釜生物反應器的公司主導。 攪拌罐一次性生物反應器領域佔據80%的市場份額，預計在預測期內將以14%的複合年增長率增長。

此外，在細胞培養類型中，哺乳動物細胞培養預計將佔據40%以上的市場份額。 值得注意的是，超過80%的一次性生物反應器適合處理哺乳動物細胞培養物。

北美和歐洲爭奪最大的市場份額

總體而言，總部位於北美和歐洲的公司目前佔據了 75% 的市場份額。 ABEC、Eppendorf、Merck Millipore、PBS Biotech 和 Thermo Fisher Scientific 等公司提供各種一次性生物反應器。 這些公司內部製造各種類型的生物反應器，包括攪拌槽生物反應器、波/感應生物反應器和氣動混合生物反應器。 此外，亞太地區的生物製藥市場呈現顯著增長，許多 CMO 在新加坡和韓國等國家建立新設施或宣布擴張。 2023年5月，Merck KgaA宣布計劃在韓國大田建設生物加工中心。 此外，包括藥明生物在內的多家公司正在新加坡投資生物製藥生產。 此外，亞太地區正在建立許多生產設施，以滿足當地消費者和小型生物製藥初創企業對生物製劑不斷增長的需求，預計這種需求將在未來幾年持續增長，並有望引領市場。

市場上的合作夥伴活動

近年來，行業利益相關者建立了多個合作夥伴關係，以加強我們在該領域的影響力，提高我們的生產能力和產品組合，以滿足對生物治療藥物不斷增長的需求。 事實上，過去 5 年該領域的合作夥伴活動複合年增長率高達 15%。 有趣的是，大多數合同是供應合同和技術集成合同。 過去五年來，該領域還發生了大量併購，表明利益相關者對該行業的興趣有所增加。

市場主要新趨勢

該行業的利益相關者正在尋找提高效率和縮短周轉時間的新方法。 這導致了該領域的多項技術進步，包括警報/警報、集成系統過程控制傳感器、電子過程日誌、遠程監控功能、觸摸屏和先進的安全法規，以提高過程效率和質量。 此外，控制器和自動化系統的集成是另一項發展，它允許將過程參數保持在所需的公差範圍內，並進行必要的調整，同時最大限度地減少人為錯誤的風險。 還值得注意的是，市場越來越多地採用生物工藝 4.0 解決方案，利用機器學習 (ML) 和人工智能進行實時過程監控。 這些進步預計將提高產量、減少浪費並開發更高質量的生物製品。 一次性技術領域的持續努力預計將在預測期內支持市場增長。

本報告研究和分析了全球一次性生物反應器市場，提供當前市場狀況、市場規模以及當前和未來機會等信息。

目錄

第一章前言

第 2 章執行摘要

第 3 章簡介

  • 章節概述
  • 一次性生物反應器概述
  • 一次性生物反應器類型
  • 一次性生物反應器的優點
  • 主要應用領域
  • 一般監管標準
  • 一次性生物反應器面臨的挑戰
  • 結論

第四章市場情況

  • 章節概述
  • 一次性生物反應器：整體市場格局
  • 一次性生物反應器製造商名單
  • 主要製造商：按產品數量分析

第 5 章主要考慮因素

  • 章節概述
  • 分析：製造商公司規模和一次性生物反應器類型
  • 分析：按操作模式劃分的一次性生物反應器類型
  • 分析：一次性生物反應器型、合成生物製劑型
  • 分析：按運營規模、細胞培養類型和合成生物製劑類型
  • 分析：按公司規模和總部地點劃分
  • 分析：按總部所在地劃分

第六章企業競爭力分析

  • 章節概述
  • 調查方法
  • 先決條件/關鍵參數
  • 一次性生物反應器製造商：公司競爭力分析

第七章北美一次性生物反應器製造商：公司簡介

  • 章節概述

第8章歐洲、亞太和其他地區的一次性生物載體製造商：公司簡介

  • 章節概述
  • 總部位於歐洲的大公司
  • 總部位於亞太地區和其他地區的主要公司

第 9 章合作夥伴和聯盟

  • 章節概述
  • 合作夥伴模式
  • 一次性生物反應器：合作夥伴和聯盟列表

第十章產品競爭力分析

  • 章節概述
  • 調查方法
  • 先決條件/關鍵參數
  • 一次性生物反應器：產品競爭力分析

第十一章品牌定位分析

  • 章節概述
  • 調查方法
  • 主要參數
  • 品牌定位矩陣
  • 品牌定位矩陣：Pall Corporation
  • 品牌定位矩陣：Biolinx Labsystems
  • 品牌定位矩陣：Eppendorf
  • 品牌定位矩陣：Solaris Biotech
  • 品牌定位矩陣：Sartorius Stedim Biotech
  • 品牌定位矩陣：Applikon Biotechnology
  • 品牌定位矩陣：Cercell

第十二章專利分析

  • 章節概述
  • 範圍和研究方法
  • 一次性生物反應器：專利分析
  • 一次性生物反應器：專利基準分析
  • 一次性生物反應器：專利評估
  • 主要專利：按引用次數分類

第十三章市場預測與機會分析

  • 章節概述
  • 主要假設和研究方法
  • 全球一次性上游生物加工技術市場（2023-2035）
  • 全球一次性生物反應器市場（2023-2035）

第 14 章案例研究：一次性生物反應器行業的關鍵創新

  • 章節概述
  • 生物反應器顯示/控制功能的創新
  • 混合技術創新
  • 一次性生物反應器的自動化
  • 結論

第15章SWOT分析

  • 章節概述
  • 一次性生物反應器：SWOT 分析
  • 優勢
  • 弱點
  • 機會
  • 威脅
  • SWOT要素比較

第 16 章案例研究：生物過程控制器和自動化系統

  • 章節概述
  • 生物過程控制軟件：總體市場格局
  • 生物過程控制軟件開發商：整體市場格局
  • 上游控制者：整體市場狀況
  • 上游控制器開發商：整體市場狀況
  • 下游控制器系統：總體市場形勢
  • 下游控制器系統開發商：整體市場形勢

第十七章結論

第 18 章管理考慮因素

  • 章節概述
  • Membio
  • Distek
  • Refine Technology
  • CerCell
  • CelVivo

第十九章附錄一：數據表

第 20 章附錄二：公司和組織名單

第 21 章附錄 III：提供生物工藝相關配件、設備和自動化解決方案的公司名單

Product Code: RA100447

INTRODUCTION

The global single use bioreactors market is estimated to be worth USD 1.3 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of ~17% during the forecast period.

Over the past few years, biopharmaceuticals have gained significant attention owing to their therapeutic efficacy. In fact, in the past two decades, over 170 biologics have received the USFDA approval, while over 10,000 biologics are currently under different stages of development. , It is a well-known fact that the commercial and clinical scale manufacturing of these complex biomolecules requires highly specialized bioprocessing equipment. Conventionally, stainless steel bioreactors were the preferred choice for production of biologics; however, to fulfill the need for high quality antibodies, cell therapies, gene therapies and other bio-therapeutics, a gradual shift towards the use of single use bioreactor has been observed. A single-use bioreactor, also known as disposable bioreactor, employs single use bioreactor bags instead of stainless steel culture vessel for the manufacturing of various biologics. Single-use bioreactors offer various advantages over conventional bioreactors; these include cost efficiency (~40%), shorter production timeline (~35%), reduction in energy and water consumption (45%-50%), better product yield and low risk of contamination. , Owing to the aforementioned benefits, various stakeholders have adopted disposable bioreactors for the manufacturing of biologics. Moreover, many single use bioreactor manufacturers are focusing on incorporating a variety of advanced features, including provisions for alerts / alarms, electronic process logs, built-in system process control sensors, touch screens, remote monitoring features, and advanced safety provisions in their proprietary offerings. In order to address the growing demand for biologics, such companies are working towards manufacturing more efficient single use bioreactors for global markets and thereby, supporting the adoption of single use technology. , The global market for single use bioreactors is anticipated to witness substantial growth during the forecast period.

SCOPE OF THE REPORT

The Single use Bioreactors Market (3rd Edition) - Distribution by Type of Bioreactor (Stirred Tank, Pneumatically Mixed, Rocker / Rotating, Wave-Induced, Paddle Sleeve, Fixed-Bed, Hollow Fibre, Diffusion, and Orbitally Shaken), Scale of Operation (Lab, Clinical and Commercial), Type of Cell Culture (Mammalian, Insect, Microbial, Viral, Plant and Bacterial), Type of Biologics Synthesized (Vaccine, Monoclonal Antibody, Recombinant Protein, Stem Cell, Cell Therapy, and Gene Therapy), Application Area (Cancer Research, Stem Cell Research, Tissue Engineering / Regenerative Medicine, Drug Discovery / Toxicity Testing and Others), End-users (Biopharmaceutical / Pharmaceutical Industries, Academic / Research Institutes), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with this industry, for the given forecast period. The market research report highlights the efforts of several stakeholders engaged in this emerging and rapidly evolving segment of the biopharmaceutical industry. Key takeaways from the study of single-use bioreactor market are briefly discussed below.

Rising Interest in Large Scale Disposable Bioreactors for Single use Bioprocessing

Several breakthroughs in the biotechnology industry, over the last few years, have provided a considerable boost to the overall growth of biopharmaceutical industry. However, in 2022, owing to the increasingly stringent regulatory guidelines related to biomanufacturing process, the new drug approvals declined by around 25%. , Hence, the growing demand for quality products has encouraged biologic manufacturers to adopt single-use bioreactor, a more advanced and long-term solution. These disposable bioreactors are cost effective and have the capability to provide operational flexibility as compared to the conventional technologies. In April 2023, mAbxience, a Spanish CDMO installed a 4000 L single-use bioreactor manufactured by ABEC, at its Leon facility. Earlier, in 2018, WuXi Biologics had also installed these 4,000 L bioreactors for large scale single use bioprocessing at their Wuxi city manufacturing facility. It is worth mentioning that ABEC, Henan Lanphan, and Thermo Fisher Scientific are amongst the key players that have launched the largest single-use bioreactors with capacity of more than 4,000 L.

The ongoing technological advancements focused on the development of improved versions of biosensors and single use bioreactor bags are likely to encourage the biopharmaceutical companies to adopt disposable bioreactor for bioprocessing, representing a lucrative opportunity for companies engaged in this growing market.

Current Single use Bioreactors Market Landscape

The single-use bioreactor market features a mix of large, mid-sized and small companies that have the required expertise to provide various types of single use bioreactors for the production of biologics. At present, more than 260 single-use bioreactors have been developed by over 60 industry stakeholders to enable the manufacturing of biologics. It is worth highlighting that majority of the single use bioreactors (~60%) offered by various manufacturers are stirred tank bioreactors. This can be attributed to the fact that stirred tank bioreactors are less likely to cause damage to the cell cultures, as these bioreactors possess optimal blade diameters and agitation speed. It is worth highlighting that constant evolution of disposable bioreactors is likely to support the development of novel and more efficacious biologics, in turn, contributing to the substantial growth of single use bioreactor market, during the forecast period.

Key Advantages Associated with Single use Bioreactors Used for the Production of Wide Variety of Biopharmaceuticals

Single use bioreactors offer various advantages over conventional stainless steel bioreactors. These advantages include ~50% reduction in total energy and water consumption and ~40% cost saving by elimination of cleaning and sterilization processes after every batch production. , Apart from the aforementioned benefits, use of single-use bioreactors also lowers the risk of cross-contamination, making these disposable bioreactors more user-friendly and efficient. Further, these systems are portable and have a smaller footprint as compared to the conventional systems, which reduces the total space required for installation. Owing to the aforementioned benefits associated with single use bioreactors, we believe that there is significant growth opportunity for the companies engaged in this industry during the forecast period.

Key Challenges Associated with the Adoption of Single use Bioreactors

One of the key challenges faced by single use bioreactor manufacturers is the reluctance of industry players to adopt these novel systems. This can be attributed to the expenses that they are likely to incur while switching to a new technology. Although, disposable bioreactors have gained significant popularity in the recent past owing to their advantages, they still pose a reasonable risk of contamination from extractables and leachable. Single use bioreactors are developed using plastic materials that can release organic or inorganic chemicals into liquid pharmaceutical products under high temperature and pressure. Potentially, these chemicals can jeopardize the safety of drug products and well-being of the patient. Further, insufficient supply of raw materials, single use components and assemblies can be another roadblock in this industry. , While disposable bioreactor manufacturers are striving to tackle these challenges through innovation in design and manufacturing methods, the current inability of single use bioreactors to operate at volume greater than 6,000 L for large scale production, remains another pressing concern.

Single use Bioreactor Market Size: Stirred Tank Single-Use Bioreactor Segment holds the Largest Market Share

The global single use bioreactors market is likely to be worth around USD 1.3 billion in 2023. Driven by the rising demand for novel biopharmaceuticals, high adoption rates of precision medicine, along with advancement in bioprocessing technologies, the single use bioreactor market is anticipated to grow at a CAGR of 17%, during the forecast period 2023-2035. Currently, the global market for single-use bioreactors is dominated by companies providing stirred tank bioreactors. The single-use stirred tank bioreactor segment captures 80% of the market share and it is likely to grow at a CAGR of 14% during the forecast period.

Additionally, in terms of type of cell culture, the mammalian cell cultures are anticipated to hold more than 40% share of the single use bioreactor market. It is worth mentioning that over 80% of the disposable bioreactors are suitable for processing mammalian cell cultures.

North America and Europe to Compete for the Largest Share of Single use Bioreactors Market

Overall, the companies based / headquartered in North America and Europe capture 75% share of the current market. Companies, such as ABEC, Eppendorf, Merck Millipore, PBS Biotech and Thermo Fisher Scientific offer a wide range of single use bioreactors. These companies have in-house single use bioreactor portfolio, with different types of bioreactors, such as stirred tank bioreactor, wave / induced bioreactor and pneumatically mixed bioreactor. Furthermore, Asia Pacific region is witnessing huge growth in biopharmaceutical market, with a number of CMOs setting up new facilities or announcing expansions in countries such as Singapore and Korea. In May 2023, Merck KgaA announced its plan to build a bioprocessing center in Daejeon City, Korea. Further, several companies, including WuXi Biologics have invested for biopharmaceutical manufacturing in Singapore. Moreover, a number of manufacturing facilities are being set up in Asia Pacific region, to meet the growing local demand for biologics from the consumers as well as the demand from small biopharmaceutical startups, which are likely to drive the market for single use bioreactors over the coming years.

Bioreactor manufacturers are continuously putting efforts to improve their product portfolio in order to address the challenges related to biomanufacturing by delivering innovative disposable bioreactors to the pharmaceutical industry. Given the ongoing efforts of stakeholders, we believe that the single use bioreactor market is poised to witness significant growth over the forecast period.

Partnership Activity in Single-use Bioreactor Market

In recent years, several partnerships have been established by industry stakeholders, in order to consolidate their presence in this field and enhance their capabilities and product portfolio to meet the growing demand for biotherapeutics. In fact, the partnership activity in this domain grew at a CAGR of ~15% over the past five years. Interestingly, most of the agreements were supply and technology integration agreements. The domain also witnessed a significant number of mergers and acquisitions during the past five years, indicating the growing interest of stakeholders in this industry.

In January 2023, Thermo Fisher Scientific entered into a manufacturing agreement with ASLAN Pharmaceuticals for the manufacturing of eblasakimab for phase III clinical studies. Sartorius Stedim Biotech has signed several deals in the past few years to provide innovative single use systems to various biomanufacturers with an aim to support manufacturing of biologics. Given the trends in this market, we believe that such deals are likely to drive the single use bioreactors market during the forecast period.

Key Emerging Trends in the Single use Bioreactor Market

Stakeholders engaged in this industry are identifying new ways to enhance efficiency and reduce turnaround time. This has led to various technological advancements in this field, which include alerts / alarms, built-in system process control sensors, electronic process logs, remote monitoring features, touch screens, and advanced safety provisions, that have demonstrated increase in efficiency and quality of the process. Further, the integration of controllers and automated systems is another advancement that allows to keep the process parameters within the desired and acceptable limits, but also make the necessary adjustments, while minimizing the risks of human errors. It is worth mentioning that the single use bioreactors market is also witnessing the adoption of bioprocessing 4.0 solutions that leverages machine learning (ML) and artificial intelligence (AI) for real-time process monitoring. Such advancements are anticipated to result into better yields, reduced waste, and development of higher quality biologics. , The ongoing efforts in the field of single use technologies will support the growth of the single use bioreactors market over the forecast period.

Leading Companies Engaged in Single Use Bioreactors Market

Examples of key companies engaged in this industry include (which have also been captured in this report) Applikon Biotechnology, Biolinx Labsystems, Celartia, Cell Culture Company, Cellexus, Cercell, CESCO Bioengineering, Cytiva, Eppendorf, Merck Millipore, Pall Corporation, PBS Biotech, PerfuseCell, ProlifeCell, Sartorius Stedim Biotech, Solaris Biotech, Synthecon and Thermo Fisher Scientific. This market report includes an easily searchable excel database of the single use bioreactor manufacturers worldwide.

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this industry, across different regions. Amongst other elements, the research report includes:

  • An executive summary of the insights captured during our research, offering a high-level view on the current state of the single use bioreactors market and its likely evolution in the mid-long term.
  • A general introduction to single use bioreactors, highlighting key technology specifications and offering details related to some of the current and future trends in this industry. It also includes a comparative summary of conventional stainless steel bioreactor and single use bioreactor. The chapter features insights related to prevalent regulatory standards, existing challenges and elaborates on the various advantages of single use bioreactors.
  • A detailed assessment of various single-use bioreactors that are either commercialized or under development. It includes detailed analysis of the overall market landscape of single use bioreactors based several relevant parameters, such as type of bioreactor (diffusion, fixed bed bioreactor, hollow fibers, pneumatically mixed, rotating bioreactor, stirred tank bioreactor, and wave induced / rocking bioreactors), scale of operation (lab, clinical and commercial), typical working volume, stirrer speed, weight of the bioreactor, advanced display / control features (alarm system, build-in system, electronic-log, remote monitoring and touch screen), mode of operation (batch, fed-batch and continuous), type of culture (2D culture and 3D culture), type of cell culture (insect, mammalian, microbial, plant, viral and others), type of biologic synthesized (cell therapies, gene therapies, monoclonal antibodies, recombinant proteins, stem cells, vaccines and others), end-users (academic, CRO, CMO and pharmaceutical / biopharmaceutical). In addition, the chapter presents the overall market landscape of companies developing single-use bioreactors, including information on their year of establishment, company size, and location of headquarters.
  • A contemporary market trend analysis, featuring a hybrid chart representation of companies engaged in this industry based on their company size and location of headquarters, a stacked bar chart representation of company size and type of single use bioreactor, a stacked bar chart representation of type of single use bioreactor and mode of operation, a heat map representation analyzing the data on the basis of the type of single use bioreactor and type of biologic synthesized, a heat map representation analyzing the data on the basis of the scale of operation, type of cell culture and type of biologic synthesized, and a world map representation highlighting the regional distribution of companies engaged in single use bioreactors market, based on the location of their headquarters.
  • An insightful four-dimensional bubble chart representation, highlighting the competitiveness of single use bioreactor manufacturers, taking into consideration the supplier strength (based on expertise of the manufacturer), product portfolio diversity and portfolio strength.
  • Tabulated profiles of key companies based in North America, Europe, Asia-Pacific and Rest of the World (shortlisted based on a proprietary criterion) engaged in developing single use bioreactors. Each company profile features a brief overview of the company, along with its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • An analysis of the recent partnerships and collaborations related to single use bioreactors, which have been established during period 2007 and 2023 (till January), based on several parameters, such as year of agreement, type of partnership (mergers / acquisitions, product / technology integration agreements, product distribution agreements, product / technology development agreements, service alliances, supply agreements, supply / distribution agreements and others), focus area (capacity expansion, geographical expansion, incorporation of automation solutions, product portfolio expansion, product development / testing, process optimization / improvement, research and development, supply of product and others), type of partner (industry and non-industry), type of biologic synthesized (antibodies, cell lines, cell therapies, gene therapies, plasmid DNA, proteins, vaccines, viral vectors and others), type of bioreactor involved (pneumatically mixed, rotating bioreactor, stirred tank bioreactor, wave induced / rocking bioreactor and others), location of facility, expanded bioreactor capacity and most active players. It also provides the regional distribution of the companies involved in these agreements.
  • A detailed product competitiveness analysis of single use bioreactors, taking into consideration several relevant parameters, such as the supplier strength (based on company's overall experience) and product competitiveness (calculated using status of development, scale of operation, type of cell culture, type of biologics synthesized, mode of operation, working volume and weight). In order to make relevant comparisons, we segregated the aforementioned products into peer groups based on the type of bioreactor (stirred tank bioreactors, fixed-bed bioreactors, wave induced / rocking bioreactors and other bioreactors).
  • An opinion on the relative popularity of the respective brands of key industry stakeholders (companies offering single-use bioreactors), based on prevalent trends. The primary purpose of this analysis is to develop an understanding on how the brands of companies are currently perceived / positioned in different market segments, relative to their competitors, based on several relevant parameters, such as portfolio strength (based on number of products), portfolio diversity (working volume, stirrer speed, weight, type of biologics synthesized and type of cell culture), years of experience, number of patents and number of partnerships. In addition, the framework can assist companies in determining improvement areas by identifying gaps within their existing capabilities, as well as recognize ways to gain competitive advantage in the mid to long term.
  • An overview of the various patents that have been filed / granted for single use bioreactors. Additionally, it features a detailed analysis of these patents, highlighting the prevalent trends related to the type of patent, publication year, application year, patent jurisdiction, focus area, Cooperative Patent Classification (CPC) symbols and type of applicant. Further, the chapter highlights the leading industry and non-industry players (in terms of number of patents filed / granted). In addition, it includes an informed patent benchmarking analysis, along with an analysis of the relative valuation of patents filed / granted for single use bioreactors based on parameters, such as patent age, region in which the patent was filed / granted and number of citations.
  • A case study on the key technological innovations, such as built-in system control sensors, advanced alarm systems, electronic-log records, touch screens, real-time tracking, remote monitoring and advanced mixing technologies, that have been introduced in the single use bioreactors industry. It also highlights the ongoing progression of automation in single use bioreactor for better bioprocess development.
  • A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall single use bioreactors industry.
  • A case study on the market landscape of bioprocess controllers and automation systems, providing information on scale of operation (laboratory, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with bioreactor system (stirred tank (glass), single-use bioreactor, stirred tank (steel), fermenter, rocking motion), type of bioprocess (batch, fed-batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of companies involved in the development of bioprocess control software, upstream and downstream controllers, including information on their respective year of establishment, company size, and location of headquarters.

One of the key objectives of the market report was to estimate the current opportunity and the future growth potential of the global single use bioreactor market over the forecast period. We have provided an informed estimate on the likely evolution of the market for the period 2023-2035. Our year-wise projections of the current and forecasted market have been further segmented based on relevant parameters, such as type of bioreactor (stirred tank, pneumatically mixed, rocker / rotating, wave-induced, paddle sleeve, fixed-bed, hollow fiber, diffusion, and orbitally shaken), scale of operation (lab, clinical and commercial), type of cell culture (mammalian, insect, microbial, viral, plant and bacterial), type of biologic synthesized (vaccine, monoclonal antibody, recombinant protein, stem cell, cell therapy, and gene therapy), application area (cancer research, stem cell research, tissue engineering / regenerative medicine, drug discovery / toxicity testing and others), end-users (biopharmaceutical / pharmaceutical industries, academic / research institutes), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios of the industry's evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The research report features detailed transcripts of interviews held with the following individuals:

  • Shane Kilpatrick (Founder and Chief Executive Officer, Membio)
  • Justin Cesmat (Manager, Bioprocessing, Distek)
  • Bradley Maykow (Quality and Products Manager, Refine Technology)
  • Per Stobbe (Chief Executive Officer, CerCell)
  • Torsten Due Bryld (Global Director of Sales Support, CelVivo)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report was gathered via primary and secondary research. For all our projects, we conduct interviews / surveys with reputed domain experts (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Question 1: What is a single use bioreactor?

Answer: Single use bioreactors are those bioreactors that use disposable bags instead of reusable stainless steel cultural vessels.

Question 2: What is the market size of single use bioreactors?

Answer: The global single use bioreactor market is anticipated to be worth around USD 1.3 billion in 2023.

Question 3: What are the factors driving the single use bioreactors market?

Answer: Advancements in bioprocessing technologies and rise in demand for novel biopharmaceuticals are the key factors driving the global single use bioreactors market.

Question 4: Who are the key players in single use bioreactors market?

Answer: Presently, more than 60 companies are engaged in single use bioreactors market, worldwide. Examples of top players engaged in this industry (full list available in the report) include Applikon Biotechnology, Biolinx Labsystems, Celartia, Cell Culture Company , Cellexus, Cercell, CESCO Bioengineering, Cytiva, Eppendorf, Merck Millipore, Pall Corporation, PBS Biotech, PerfuseCell, ProlifeCell, Sartorius Stedim Biotech, Solaris Biotech, Synthecon and Thermo Fisher Scientific.

Question 5: Which region has the largest share in single use bioreactors market?

Answer: North America and Europe captures around 75% of the current single use bioreactors market, followed by Asia-Pacific.

Question 6: Which type of single use bioreactor has the largest share in the global single use bioreactor market?

Answer: Currently, the global single use bioreactor market is dominated by the companies providing stirred tank single use bioreactors. The stirred tank bioreactor market captures 80% market share and it is likely to grow at a CAGR of 14%, during the forecast period.

Question 7: Which are the leading market segments in global single use bioreactor market, in terms of type of biologic synthesized?

Answer: Our estimates suggest that monoclonal antibodies capture more than 25% share in the overall global single use bioreactor market.

Question 8: What is the growth rate of single use bioreactors market?

Answer: The global single use bioreactor market is projected to grow at a CAGR of ~17% during the forecast period.

CHAPTER OUTLINES

  • Chapter 1: is a preface providing an introduction to the full report, Single use Bioreactors Market, 2023-2035.
  • Chapter 2: is an executive summary of the insights captured during our research, offering a high-level view on the current state of the single use bioreactors market and its likely evolution in the mid-long term.
  • Chapter 3: provides a general introduction to single use bioreactors, highlighting key technology specifications and offering details related to some of the current and future trends in this industry. It also includes a comparative summary of conventional stainless steel bioreactor and single use bioreactor. The chapter features insights related to prevalent regulatory standards, existing challenges and elaborates on the various advantages of single use bioreactors.
  • Chapter 4: includes a detailed assessment of various single-use bioreactors that are either commercialized or under development. It includes detailed analyses of the overall market landscape of single use bioreactors based several relevant parameters, such as type of bioreactor (diffusion, fixed bed bioreactor, hollow fibers, pneumatically mixed, rotating bioreactor, stirred tank bioreactor, and wave induced / rocking bioreactors), scale of operation (lab, clinical and commercial), typical working volume, stirrer speed, weight of the bioreactor, advanced display / control features (alarm system, build-in system, electronic-log, remote monitoring and touch screen), mode of operation (batch, fed-batch and continuous), type of culture (2D culture and 3D culture), type of cell culture (insect, mammalian, microbial, plant, viral and others), type of biologics synthesized (cell therapies, gene therapies, monoclonal antibodies, recombinant proteins, stem cells, vaccines and others), end-users (academic, CRO, CMO and pharmaceutical / biopharmaceutical). In addition, the chapter presents the overall market landscape of companies developing single-use bioreactors, including information on their year of establishment, company size, and location of headquarters.
  • Chapter 5: presents a contemporary market trend analysis, featuring a hybrid chart representation of companies engaged in this industry based on their company size and location of headquarters, a stacked bar chart representation of company size and type of single use bioreactor, a stacked bar chart representation of type of single use bioreactor and mode of operation, a heat map representation analyzing the data on the basis of the type of single use bioreactor and type of biologics synthesized, a heat map representation analyzing the data on the basis of the scale of operation, type of cell culture and type of biologics synthesized, and a world map representation highlighting the regional distribution of companies engaged in single use bioreactors market, based on the location of their headquarters.
  • Chapter 6: highlights an insightful four-dimensional bubble chart representation, highlighting the competitiveness of single use bioreactor manufacturers, taking into consideration the supplier strength (based on expertise of the manufacturer), product portfolio diversity and portfolio strength.
  • Chapter 7: presents tabulated profiles of key companies based in North America, Europe, Asia-Pacific and Rest of the World (shortlisted based on a proprietary criterion) engaged in developing single use bioreactors. Each company profile features a brief overview of the company, along with its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • Chapter 8: presents tabulated profiles of key players based in Europe, Asia-Pacific and Rest of the World (shortlisted based on a proprietary criterion) engaged in developing single use bioreactors. Each company profile features a brief overview of the company, along with its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • Chapter 9: presents an analysis of the recent partnerships and collaborations related to single use bioreactors, which have been established during period 2007 and 2023 (till January), based on several parameters, such as year of agreement, type of partnership (mergers / acquisitions, product / technology integration agreements, product distribution agreements, product / technology development agreements, service alliances, supply agreements, supply / distribution agreements and others), focus area (capacity expansion, geographical expansion, incorporation of automation solutions, product portfolio expansion, product development / testing, process optimization / improvement, research and development, supply of product and others), type of partner (industry and non-industry), type of biologics synthesized (antibodies, cell lines, cell therapies, gene therapies, plasmid DNA, proteins, vaccines, viral vectors and others), type of bioreactor involved (pneumatically mixed, rotating bioreactor, stirred tank bioreactor, wave induced / rocking bioreactor and others), location of facility, expanded bioreactor capacity and most active players. It also provides the regional distribution of the companies involved in these agreements.
  • Chapter 10: presents a detailed product competitiveness analysis of single use bioreactors, taking into consideration several relevant parameters, such as the supplier strength (based on company's overall experience) and product competitiveness (calculated using status of development, scale of operation, type of cell culture, type of biologics synthesized, mode of operation, working volume and weight). In order to make relevant comparisons, we segregated the aforementioned products into peer groups based on the type of bioreactor (stirred tank bioreactors, fixed-bed bioreactors, wave induced / rocking bioreactors and other bioreactors)..
  • Chapter 11: presents an opinion on the relative popularity of the respective brands of key industry stakeholders (companies offering single-use bioreactors), based on prevalent trends. The primary purpose of this analysis is to develop an understanding on how the brands of companies are currently perceived / positioned in different market segments, relative to their competitors, based on several relevant parameters, such as portfolio strength (based on number of products), portfolio diversity (working volume, stirrer speed, weight, type of biologics synthesized and type of cell culture), years of experience, number of patents and number of partnerships. In addition, the framework can assist companies in determining improvement areas by identifying gaps within their existing capabilities, as well as recognize ways to gain competitive advantage in the mid to long term.
  • Chapter 12: features an overview of the various patents that have been filed / granted for single use bioreactors. Additionally, it features a detailed analysis of these patents, highlighting the prevalent trends related to the type of patent, publication year, application year, patent jurisdiction, focus area, Cooperative Patent Classification (CPC) symbols and type of applicant. Further, the chapter highlights the leading industry and non-industry players (in terms of number of patents filed / granted). In addition, it includes an informed patent benchmarking analysis, along with an analysis of the relative valuation of patents filed / granted for single use bioreactors based on parameters, such as patent age, region in which the patent was filed / granted and number of citations.
  • Chapter 13: presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of bioreactor (stirred tank, pneumatically mixed, rocker / rotating, wave-induced, paddle sleeve, fixed-bed, hollow fiber, diffusion, and orbitally shaken), scale of operation (lab, clinical and commercial), type of cell culture (mammalian, insect, microbial, viral, plant and bacterial), type of biologics synthesized (vaccine, monoclonal antibody, recombinant protein, stem cell, cell therapy, and gene therapy), application area (cancer research, stem cell research, tissue engineering / regenerative medicine, drug discovery / toxicity testing and others), end-users (biopharmaceutical / pharmaceutical industries, academic / research institutes), and key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa).
  • Chapter 14: presents a case study on the key technological innovations, such as built-in system control sensors, advanced alarm systems, electronic-log records, touch screens, real-time tracking, remote monitoring and advanced mixing technologies, that have been introduced in the single use bioreactors industry. It also highlights the ongoing progression of automation in single use bioreactor for better bioprocess development.
  • Chapter 15: presents a discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall single use bioreactors industry.
  • Chapter 16: presents a case study on the market landscape of bioprocess controllers and automation systems, providing information on scale of operation (laboratory, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with bioreactor system (stirred tank (glass), single-use bioreactor, stirred tank (steel), fermenter, rocking motion), type of bioprocess (batch, fed-batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of companies involved in the development of bioprocess control software, upstream and downstream controllers, including information on their respective year of establishment, company size, and location of headquarters.
  • Chapter 17: is a summary of the overall report. The chapter provides the key takeaways from the report, and presents facts and figures described in the previous chapters. The chapter also highlights important evolutionary trends that were identified during the course of the study and are expected to influence the future of the single use bioreactor market.
  • Chapter 18: is a collection of transcripts of interviews conducted with various stakeholders in the industry. We have presented details of interviews held with Shane Kilpatrick (Chief Executive Officer and Founder, Membio), Justin Cesmat (Manager of Bioprocessing, Distek), Bradley Maykow (Quality and Products Manager, Refine Technology), Per Stobbe (Chief Strategy Officer of R&D, Marketing and Technical Support, CerCell) and Torsten Due Bryld (Global Director of Sales Support, CelVivo).
  • Chapter 19: is an appendix, which contains tabulated data and numbers for all the figures included in this report.
  • Chapter 20: is an appendix, which contains a list of companies and organizations mentioned in this report.
  • Chapter 21: is an appendix, which contains a list of businesses offering accessories, equipment, and automation solutions.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Single-use Bioreactors
    • 3.2.1. Historical Evolution
    • 3.2.2. Single-use versus Traditional Bioreactors
  • 3.3. Types of Single-use Bioreactors
    • 3.3.1. Based on Cell Culture
    • 3.3.2. Based on Agitation Mechanism
  • 3.4. Advantages of Single-use Bioreactors
  • 3.5. Key Applications Areas
  • 3.6. Prevalent Regulatory Standards
  • 3.7. Challenges Associated with Single-use Bioreactors
  • 3.8. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Single-use Bioreactors: Overall Market Landscape
    • 4.2.1. Analysis by Type of Bioreactor
    • 4.2.2. Analysis by Scale of Operation
    • 4.2.3. Analysis by Working Volume
    • 4.2.4. Analysis by Stirrer Speed
    • 4.2.5. Analysis by Weight of Bioreactor
    • 4.2.6. Analysis by Advanced Display / Control Features
    • 4.2.7. Analysis by Mode of Operation
    • 4.2.8. Analysis by Type of Culture
    • 4.2.9. Analysis by Type of Cell Culture
    • 4.2.10. Analysis by Type of Biologics Synthesized
    • 4.2.11. Analysis by End-users
  • 4.3. List of Single-use Bioreactor Manufacturers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters (Region)
    • 4.3.4. Analysis by Location of Headquarters (Country)
  • 4.4. Leading Manufacturers: Analysis by Number of Products

5. KEY INSIGHTS

  • 5.1. Chapter Overview
  • 5.2. Analysis by Company Size of Manufacturer and Type of Single-use Bioreactor
  • 5.3. Analysis by Type of Single-use Bioreactor and Mode of Operation
  • 5.4. Analysis by Type of Single-use Bioreactor and Type of Biologics Synthesized
  • 5.5. Analysis by Scale of Operation, Type of Cell Culture and Type of Biologics Synthesized
  • 5.6. Analysis by Company Size and Location of Headquarters
  • 5.7. Analysis by Location of Headquarters

6. COMPANY COMPETITIVENESS ANALYSIS

  • 6.1. Chapter Overview
  • 6.2. Methodology
  • 6.3. Assumptions / Key Parameters
  • 6.4. Single-use Bioreactor Manufacturers: Company Competitiveness Analysis
    • 6.4.1. Small Companies
    • 6.4.2. Mid-sized Companies
    • 6.4.3. Large Companies

7. SINGLE-USE BIOREACTOR MANUFACTURERS IN NORTH AMERICA: COMPANY PROFILES

  • 7.1. Chapter Overview
    • 7.2.1. Celartia
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Product Portfolio
      • 7.2.1.3. Recent Developments and Future Outlook
    • 7.2.2. Cell Culture Company
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Product Portfolio
      • 7.2.2.3. Recent Developments and Future Outlook
    • 7.2.3. Cytiva
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Product Portfolio
      • 7.2.3.3. Recent Developments and Future Outlook
    • 7.2.4. Merck Millipore
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Information
      • 7.2.4.3. Product Portfolio
      • 7.2.4.4. Recent Developments and Future Outlook
    • 7.2.5. Pall Corporation
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Product Portfolio
      • 7.2.5.3. Recent Developments and Future Outlook
    • 7.2.6. PBS Biotech
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Product Portfolio
      • 7.2.6.3. Recent Developments and Future Outlook
    • 7.2.7. Synthecon
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Product Portfolio
      • 7.2.7.3. Recent Developments and Future Outlook
    • 7.2.8. Thermo Fisher Scientific
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Information
      • 7.2.8.3. Product Portfolio
      • 7.2.8.4. Recent Developments and Future Outlook

8. SINGLE-USE BIORECTOR MANUFACTURERS IN EUROPE, ASIA-PACIFIC AND REST OF THE WORLD: COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Leading Players based in Europe
    • 8.2.1. Applikon Biotechnology
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Product Portfolio
      • 8.2.1.3. Recent Developments and Future Outlook
    • 8.2.2. Cellexus
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Product Portfolio
      • 8.2.2.3. Recent Developments and Future Outlook
    • 8.2.3. CerCell
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Product Portfolio
      • 8.2.3.3. Recent Developments and Future Outlook
    • 8.2.4. Eppendorf
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Information
      • 8.2.4.3. Product Portfolio
      • 8.2.4.4. Recent Developments and Future Outlook
    • 8.2.5. PerfuseCell
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Product Portfolio
      • 8.2.5.3. Recent Developments and Future Outlook
    • 8.2.6. ProlifeCell
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Product Portfolio
      • 8.2.6.3. Recent Developments and Future Outlook
    • 8.2.7. Sartorius Stedim Biotech
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Information
      • 8.2.7.3. Product Portfolio
      • 8.2.7.4. Recent Developments and Future Outlook
    • 8.2.8. Solaris Biotech
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Product Portfolio
      • 8.2.8.3. Recent Developments and Future Outlook
  • 8.3. Leading Players based in Asia-Pacific and Rest of the World
    • 8.3.1. Biolinx Labsystems
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Product Portfolio
      • 8.3.1.3. Recent Developments and Future Outlook
    • 8.3.2. CESCO Bioengineering
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Product Portfolio
      • 8.3.2.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Single-use Bioreactors: List of Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Analysis by Year of Partnership and Focus Area
    • 9.3.6. Analysis by Type of Partner
    • 9.3.7. Analysis by Type of Biologics Synthesized
    • 9.3.8. Analysis by Type of Bioreactor Involved
    • 9.3.9. Analysis by Location of Facility (Country) and Expanded Bioreactor Capacity
    • 9.3.10. Most Active Players: Analysis by Number of Partnerships
    • 9.3.11. Analysis by Geography
      • 9.3.11.1. Local and International Agreements
      • 9.3.11.2. Intracontinental and Intercontinental Agreements

10. PRODUCT COMPETITIVENESS ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Methodology
  • 10.3. Assumptions / Key Parameters
  • 10.4. Single-use Bioreactors: Product Competitiveness Analysis
    • 10.4.1. Stirred Tank Single-use Bioreactors
      • 10.4.1.1 Products Offered by Players based In North America
      • 10.4.1.2 Products Offered by Players based In Europe
      • 10.4.1.3 Products Offered by Players based In Asia-Pacific and Rest of the World
    • 10.4.2 Fixed-Bed Single-use Bioreactors
    • 10.4.3 Wave-Induced / Rocking Single-use Bioreactors
    • 10.4.4. Other Types of Single-use Bioreactors
      • 10.4.4.1 Products Offered by Players based In North America
      • 10.4.4.2 Products Offered by Players based In Europe
      • 10.4.4.3 Products Offered by Players based In Asia-Pacific and Rest of the World

11. BRAND POSITIONING ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Methodology
  • 11.3. Key Parameters
  • 11.4. Brand Positioning Matrix
  • 11.5. Brand Positioning Matrix: Pall Corporation
  • 11.6. Brand Positioning Matrix: Biolinx Labsystems
  • 11.7. Brand Positioning Matrix: Eppendorf
  • 11.8. Brand Positioning Matrix: Solaris Biotech
  • 11.9. Brand Positioning Matrix: Sartorius Stedim Biotech
  • 11.10. Brand Positioning Matrix: Applikon Biotechnology
  • 11.11. Brand Positioning Matrix: Cercell

12. PATENT ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Scope and Methodology
  • 12.3. Single-use Bioreactors: Patent Analysis
    • 12.3.1. Analysis by Application Year
    • 12.3.2. Analysis by Publication Year
    • 12.3.3. Analysis by Type of Patents and Publication Year
    • 12.3.4. Analysis by Patent Jurisdiction
    • 12.3.5. Analysis by CPC Symbols
    • 12.3.6. Analysis by Type of Applicant
    • 12.3.7. Leading Industry Players: Analysis by Number of Patents
    • 12.3.8. Leading Patent Assignees: Analysis by Number of Patents
  • 12.4. Single-use Bioreactors: Patent Benchmarking Analysis
    • 12.4.1. Analysis by Patent Characteristics
  • 12.5. Single-use Bioreactors: Patent Valuation
  • 12.6. Leading Patents by Number of Citations

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Global Single-use Upstream Bioprocessing Technology Market, 2023-2035
    • 13.3.1. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, 2023-2035
    • 13.3.2. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, 2023-2035
    • 13.3.3. Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, 2023-2035
  • 13.4. Global Single-use Bioreactors Market, 2023-2035
    • 13.4.1. Global Single-use Bioreactors Market: Distribution by Type of Bioreactor, 2023-2035
    • 13.4.2. Global Single-use Bioreactors Market: Distribution by Scale of Operation, 2023-2035
    • 13.4.3. Global Single-use Bioreactors Market: Distribution by Type of Cell Culture, 2023-2035
    • 13.4.4. Global Single-use Bioreactors Market: Distribution by Type of Biologics Synthesized, 2023-2035
    • 13.4.5. Global Single-use Bioreactors Market: Distribution by Application Area, 2023- 2035
    • 13.4.6. Global Single-use Bioreactors Market: Distribution by End-users, 2023-2035
    • 13.4.7. Global Single-use Bioreactors Market: Distribution by Geographical Region, 2023-2035

14. CASE STUDY: KEY TECHNOLOGICAL INNOVATIONS IN THE SINGLE-USE BIOREACTORS INDUSTRY

  • 14.1. Chapter Overview
  • 14.2. Innovations in Bioreactor Display / Control Features
    • 14.2.1. Built-in System Control Sensors
    • 14.2.2. Advanced Alarm Systems
    • 14.2.3. Electronic-Log Records and Touch Screens
    • 14.2.4. Real-Time Tracking and Remote Monitoring
  • 14.3. Innovation in Mixing Technologies
  • 14.4. Automation in Single-use bioreactors
  • 14.5. Concluding Remarks

15. SWOT ANALYSIS

  • 15.1. Chapter Overview
  • 15.2. Single-use Bioreactors: SWOT Analysis
  • 15.3. Strengths
  • 15.4. Weaknesses
  • 15.5. Opportunities
  • 15.6. Threats
  • 15.7. Comparison of SWOT Factors

16. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS

  • 16.1. Chapter Overview
  • 16.2. Bioprocess Control Software: Overall Market Landscape
    • 16.2.1. Analysis by Scale of Operation
    • 16.2.2. Analysis by Key Features
    • 16.2.3. Analysis by Compatibility with System
    • 16.2.4. Analysis by Type of Process Controlled
  • 16.3. Bioprocess Control Software Developers: Overall Market Landscape
    • 16.3.1. Analysis by Year of Establishment
    • 16.3.2. Analysis by Company Size
    • 16.3.3. Analysis by Location of Headquarters
  • 16.4. Upstream Controllers: Overall Market Landscape
    • 16.4.1. Analysis by Scale of Operation
    • 16.4.2. Analysis by Key Features
    • 16.4.3. Analysis by Compatibility with Bioreactor System
    • 16.4.4. Analysis by Type of Bioprocess
    • 16.4.5. Analysis by Type of Process Controlled
  • 16.5. Upstream Controller Developers: Overall Market Landscape
    • 16.5.1. Analysis by Year of Establishment
    • 16.5.2. Analysis by Company Size
    • 16.5.3. Analysis by Location of Headquarters
  • 16.6. Downstream Controller Systems: Overall Market Landscape
    • 16.6.1. Analysis by Scale of Operation
    • 16.6.2. Analysis by Key Features
    • 16.6.3. Analysis by Type of System
    • 16.6.4. Analysis by Type of Bioprocess
    • 16.6.5. Analysis by Application Area
  • 16.7. Downstream Controller System Developers: Overall Market Landscape
    • 16.7.1. Analysis by Year of Establishment
    • 16.7.2. Analysis by Company Size
    • 16.7.3. Analysis by Location of Headquarters

17. CONCLUSION

18. EXECUTIVE INSIGHTS

  • 18.1. Chapter Overview
  • 18.2. Membio
    • 18.2.1. Company Snapshot
    • 18.2.2. Interview Transcript: Shane Kilpatrick, Founder and Chief Executive Officer
  • 18.3. Distek
    • 18.3.1. Company Snapshot
    • 18.3.2. Interview Transcript: Justin Cesmat, Manager, Bioprocessing
  • 18.4. Refine Technology
    • 18.4.1. Company Snapshot
    • 18.4.2. Interview Transcript: Bradley Maykow, Quality and Products Manager
  • 18.5. CerCell
    • 18.5.1. Company Snapshot
    • 18.5.2. Interview Transcript: Per Stobbe, Chief Executive Officer
  • 18.6. CelVivo
    • 18.6.1. Company Snapshot
    • 18.6.2. Interview Transcript: Torsten Due Bryld, Global Director of Sales Support

19. APPENDIX I: TABULATED DATA

20. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

21. APPENDIX III: LIST OF BUSINESSES OFFERING BIOPROCESS RELATED ACCESSORIES, EQUIPMENT, AND AUTOMATION SOLUTIONS

LIST OF TABLES

  • Table 3.1 Comparison between Conventional and Single-use Bioreactors
  • Table 4.1 Single-use Bioreactors: Information on Manufacturer, Status of Development, Type of Bioreactor and Scale of Operation
  • Table 4.2 Single-use Bioreactors: Information on Working Volume, Stirrer Speed, Weight and Dimensions of Bioreactor
  • Table 4.3 Single-use Bioreactors: Information on Advanced Display / Control Features
  • Table 4.4 Single-use Bioreactors: Information on Mode of Operation
  • Table 4.5 Single-use Bioreactors: Information on Type of Culture and Type of Cell Culture
  • Table 4.6 Single-use Bioreactors: Information on Type of Biologics Synthesized
  • Table 4.7 Single-use Bioreactors: Information on End-users
  • Table 4.8 Single-use Bioreactors: List of Manufacturers
  • Table 7.1 Single-use Bioreactors: List of Companies Profiled
  • Table 7.2 Celartia: Company Snapshot
  • Table 7.3 Celartia: Product Portfolio
  • Table 7.4 Cell Culture Company: Company Snapshot
  • Table 7.5 Cell Culture Company: Product Portfolio
  • Table 7.6 Cytiva: Company Snapshot
  • Table 7.7 Cytiva: Product Portfolio
  • Table 7.8 Merck Millipore: Company Snapshot
  • Table 7.9 Merck Millipore: Product Portfolio
  • Table 7.10 Merck Millipore: Recent Developments and Future Outlook
  • Table 7.11 Pall Corporation: Company Snapshot
  • Table 7.12 Pall Corporation: Product Portfolio
  • Table 7.13 Pall Corporation: Recent Developments and Future Outlook
  • Table 7.14 PBS Biotech: Company Snapshot
  • Table 7.15 PBS Biotech: Product Portfolio
  • Table 7.16 PBS Biotech: Recent Developments and Future Outlook
  • Table 7.17 Synthecon: Company Snapshot
  • Table 7.18 Synthecon: Product Portfolio
  • Table 7.19 Thermo Fisher Scientific: Company Snapshot
  • Table 7.20 Thermo Fisher Scientific: Product Portfolio
  • Table 7.21 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 8.1 Single-use Bioreactors: List of Companies Profiled
  • Table 8.2 Applikon Biotechnology: Company Snapshot
  • Table 8.3 Applikon Biotechnology: Product Portfolio
  • Table 8.4 Applikon Biotechnology: Recent Developments and Future Outlook
  • Table 8.5 Cellexus: Company Snapshot
  • Table 8.6 Cellexus: Product Portfolio
  • Table 8.7 Cellexus: Recent Developments and Future Outlook
  • Table 8.8 CerCell: Company Snapshot
  • Table 8.9 CerCell: Product Portfolio
  • Table 8.10 CerCell: Recent Developments and Future Outlook
  • Table 8.11 Eppendorf: Company Snapshot
  • Table 8.12 Eppendorf: Product Portfolio
  • Table 8.13 Eppendorf: Recent Developments and Future Outlook
  • Table 8.14 PerfuseCell: Company Snapshot
  • Table 8.15 PerfuseCell: Product Portfolio
  • Table 8.16 PerfuseCell: Recent Developments and Future Outlook
  • Table 8.17 ProlifeCell: Company Snapshot
  • Table 8.18 ProlifeCell: Product Portfolio
  • Table 8.19 ProlifeCell: Recent Developments and Future Outlook
  • Table 8.20 Sartorius Stedim Biotech: Company Snapshot
  • Table 8.21 Sartorius Stedim Biotech: Product Portfolio
  • Table 8.22 Sartorius Stedim Biotech: Recent Developments and Future Outlook
  • Table 8.21 Solaris Biotech: Company Snapshot
  • Table 8.22 Solaris Biotech: Product Portfolio
  • Table 8.23 Solaris Biotech: Recent Developments and Future Outlook
  • Table 8.24 Biolinx Labsystems: Company Snapshot
  • Table 8.25 Biolinx Labsystems: Product Portfolio
  • Table 8.26 CESCO Bioengineering: Company Snapshot
  • Table 8.27 CESCO Bioengineering: Product Portfolio
  • Table 9.1 Single-use Bioreactors: List of Partnerships and Collaborations
  • Table 9.2 Single-use Bioreactors: Information on Location of Partner (Country and Continent)
  • Table 10.1 Product Competitiveness Analysis: Information on Peer Groups
  • Table 12.1 Patent Analysis: Top CPC Sections
  • Table 12.2 Patent Analysis: Top CPC Symbols
  • Table 12.3 Patent Analysis: Top CPC Codes
  • Table 12.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 12.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 12.6 Patent Analysis: List of Leading Patents (by Number of Citations)
  • Table 16.1 Bioprocess Control Software: Information on Stage of Bioprocess and Scale of Operation
  • Table 16.2 Bioprocess Control Software: Information on Key Features, Compatibility with Bioreactor Systems and Processes Controlled
  • Table 16.3 Bioprocess Control Software Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 16.4 Upstream Controllers: Information on Dimensions and Scale of Operation
  • Table 16.5 Upstream Controllers: Information on Key Features, Type of Bioprocess and Compatibility with Bioreactor Systems, and Processes Controlled
  • Table 16.6 Upstream Controller Developers: Information on Year of Establishment, Company Size and Location of Headquarters
  • Table 16.7 Downstream Controller Systems: Information on Dimensions, Type of Controllers and Scale of Operation
  • Table 16.8 Downstream Controller Systems: Information on Key Features, Type of System, Type of Bioprocess and Application Areas
  • Table 16.9 Downstream Controller System Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 18.1 Membio: Company Snapshot
  • Table 18.2 Distek: Company Snapshot
  • Table 18.3 Refine Technology: Company Snapshot
  • Table 18.4 CerCell: Company Snapshot
  • Table 18.5 CelVivo: Company Snapshot
  • Table 19.1 Conventional, Stainless-steel Bioreactors and Single-use Bioreactors: Energy Consumption (Mega Joules)
  • Table 19.2 Conventional, Stainless-steel Bioreactors and Single-use Bioreactors: Water Consumption (Kilo Liters)
  • Table 19.3 Single-use Bioreactors: Distribution by Type of Bioreactor
  • Table 19.4 Single-use Bioreactors: Distribution by Scale of Operation
  • Table 19.5 Single-use Bioreactors: Distribution by Working Volume (Liters)
  • Table 19.6 Single-use Bioreactors: Distribution by Stirrer speed (RPM)
  • Table 19.7 Single-use Bioreactors: Distribution by Weight of Bioreactor (Kg)
  • Table 19.8 Single-use Bioreactors: Distribution by Advanced Display / Control Features
  • Table 19.9 Single-use Bioreactors: Distribution by Mode of Operation
  • Table 19.10 Single-use Bioreactors: Distribution by Type of Culture
  • Table 19.11 Single-use Bioreactors: Distribution by Type of Cell Culture
  • Table 19.12 Single-use Bioreactors: Distribution by Type of Biologics Synthesized
  • Table 19.13 Single-use Bioreactors: Distribution by End-users
  • Table 19.14 Single-use Bioreactor Manufacturers: Distribution by Year of Establishment
  • Table 19.15 Single-use Bioreactor Manufacturers: Distribution by Company Size
  • Table 19.16 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Region)
  • Table 19.17 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Country)
  • Table 19.18 Leading Manufacturers: Distribution by Number of Products
  • Table 19.19 Single-use Bioreactor Manufacturers: Distribution by Company Size of manufacturer and Type of Single-use Bioreactor
  • Table 19.20 Single-use Bioreactors: Distribution by Type of Single-use Bioreactor and Mode of Operation
  • Table 19.21 Single-use Bioreactor Manufacturers: Distribution by Company Size and Location of Headquarters
  • Table 19.22 Merck Millipore: Annual Revenues, 2017-2022 (EUR Billion)
  • Table 19.23 Thermo Fisher Scientific: Annual Revenues, 2017-2022 (USD Billion)
  • Table 19.24 Eppendorf: Annual Revenues, 2018-2022 (EUR Million)
  • Table 19.25 Sartorius Stedim Biotech: Annual Revenues, 2018-Q1 2023 (EUR Million)
  • Table 19.26 Partnerships and Collaborations: Cumulative Year-Wise Trend
  • Table 19.27 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 19.28 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 19.29 Partnerships and Collaborations: Distribution by Focus Area
  • Table 19.30 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
  • Table 19.31 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 19.32 Partnerships and Collaborations: Distribution by Type of Biologics Synthesized
  • Table 19.33 Partnerships and Collaborations: Distribution by Type of Bioreactor Involved
  • Table 19.34 Most Active Players: Distribution by Number of Partnerships
  • Table 19.35 Partnerships and Collaborations: Local and International Agreements
  • Table 19.36 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Table 19.37 Patent Analysis: Distribution by Type of Patent
  • Table 19.38 Patent Analysis: Cumulative Year-wise Trend by Application Year, Pre-2015- 2023
  • Table 19.39 Patent Analysis: Cumulative Year-wise Trend by Publication Year, Pre-2015- 2023
  • Table 19.40 Patent Analysis: Distribution of Type of Patents and Publication Year, Pre-2015- 2023
  • Table 19.41 Patent Analysis: Distribution by Patent Jurisdiction
  • Table 19.42 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
  • Table 19.43 Leading Industry Players: Distribution by Number of Patents
  • Table 19.44 Leading Patent Assignees: Distribution by Number of Patents
  • Table 19.45 Patent Analysis: Distribution by Patent Age
  • Table 19.46 Single-use Bioreactors: Patent Valuation
  • Table 19.47 Global Single-use Upstream Bioprocessing Technology Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.48 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.49 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.50 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.51 Global Single-use Bioreactor Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.52 Global Single-use Bioreactor Market: Distribution by Type of Bioreactor, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.53 Global Single-use Bioreactor Market: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.54 Global Single-use Bioreactor Market: Distribution by Type of Cell Culture, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.55 Global Single-use Bioreactor Market: Distribution by Type of Biologics Synthesized, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.56 Global single-use Bioreactor Market: Distribution by Application Area, Conservative, Base and Optimistic Scenario,2023-2035 (USD Billion)
  • Table 19.57 Global single-use Bioreactor Market: Distribution by End-users, Conservative, Base and Optimistic Scenario,2023-2035 (USD Billion)
  • Table 19.58 Global Single-use Bioreactor Market: Distribution by Geographical Region, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Billion)
  • Table 19.59 Bioprocess Control Software: Distribution by Scale of Operation
  • Table 19.60 Bioprocess Control Software: Distribution by Key Features
  • Table 19.61 Bioprocess Control Software: Distribution by Compatibility with Systems
  • Table 19.62 Bioprocess Control Software: Distribution by Type of Process Controlled
  • Table 19.63 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Table 19.64 Bioprocess Control Software Developers: Distribution by Company Size
  • Table 19.65 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Table 19.66 Upstream Controllers: Distribution by Scale of Operation
  • Table 19.67 Upstream Controllers: Distribution by Key Features
  • Table 19.68 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Table 19.69 Upstream Controllers: Distribution by Type of Bioprocess
  • Table 19.70 Upstream Controllers: Distribution by Type of Process Controlled
  • Table 19.71 Upstream Controller Developers: Distribution by Year of Establishment
  • Table 19.72 Upstream Controller Developers: Distribution by Company Size
  • Table 19.73 Upstream Controller Developers: Distribution by Location of Headquarters
  • Table 19.74 Downstream Controller Systems: Distribution by Scale of Operation
  • Table 19.75 Downstream Controller Systems: Distribution by Key Features
  • Table 19.76 Downstream Controller Systems: Distribution by Type of System
  • Table 19.77 Downstream Controller Systems: Distribution by Type of Bioprocess
  • Table 19.78 Downstream Controller Systems: Distribution by Application Area
  • Table 19.79 Downstream Controller System Developers: Distribution by Year of Establishment
  • Table 19.80 Downstream Controller System Developers: Distribution by Company Size
  • Table 19.81 Downstream Controller System Developers: Distribution by Location of Headquarters

LIST OF FIGURES

  • Figure 2.1 Executive Summary: Current Market Landscape of Single-use Bioreactors
  • Figure 2.2 Executive Summary: Partnerships and Collaborations
  • Figure 2.3 Executive Summary: Patent Analysis
  • Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Historical Events related to the Development of Single-use Bioreactors
  • Figure 3.2 Conventional, Stainless-steel Bioreactors and Single-use Bioreactors: Energy Consumption (Mega Joules)
  • Figure 3.3 Conventional, Stainless-steel Bioreactors and Single-use Bioreactors: Water Consumption (Kilo Liters)
  • Figure 3.4 Single-use Bioreactors: Information on Type of Cell Culture Handled
  • Figure 3.5 Advantages of Single-use Bioreactors
  • Figure 3.6 Applications of Single-use Bioreactors
  • Figure 4.1 Single-use Bioreactors: Distribution by Type of Bioreactor
  • Figure 4.2 Single-use Bioreactors: Distribution by Scale of Operation
  • Figure 4.3 Single-use Bioreactors: Distribution by Working Volume (Liters)
  • Figure 4.4 Single-use Bioreactors: Distribution by Stirrer speed (RPM)
  • Figure 4.5 Single-use Bioreactors: Distribution by Weight of Bioreactor (Kg)
  • Figure 4.6 Single-use Bioreactors: Distribution by Advanced Display / Control Features
  • Figure 4.7 Single-use Bioreactors: Distribution by Mode of Operation
  • Figure 4.8 Single-use Bioreactors: Distribution by Type of Culture
  • Figure 4.9 Single-use Bioreactors: Distribution by Type of Cell Culture
  • Figure 4.10 Single-use Bioreactors: Distribution by Type of Biologics Synthesized
  • Figure 4.11 Single-use Bioreactors: Distribution by End-users
  • Figure 4.12 Single-use Bioreactor Manufacturers: Distribution by Year of Establishment
  • Figure 4.13 Single-use Bioreactor Manufacturers: Distribution by Company Size
  • Figure 4.14 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Region)
  • Figure 4.15 Single-use Bioreactor Manufacturers: Distribution by Location of Headquarters (Country)
  • Figure 4.16 Leading Manufacturers: Distribution by Number of Products
  • Figure 5.1 Single-use Bioreactor Manufacturers: Distribution by Company Size of manufacturer and Location of Headquarters
  • Figure 5.2 Single-use Bioreactors: Distribution by Type of Single-use Bioreactor and Mode of Operation
  • Figure 5.3 Heat Map Representation: Distribution by Type of Single-use Bioreactor and Type of Biologics Synthesized
  • Figure 5.4 Single-use Bioreactor Manufacturers: Distribution by Company Size and Type of Single-use Bioreactor
  • Figure 5.5 Distribution by Scale of Operation, Type of Cell Culture and Type of Biologics Synthesized
  • Figure 5.6 World Map Representation: Distribution by Location of Headquarters
  • Figure 6.1 Company Competitiveness Analysis: Small Companies
  • Figure 6.2 Company Competitiveness Analysis: Mid-sized Companies
  • Figure 6.3 Company Competitiveness Analysis: Large Companies
  • Figure 7.1 Merck Millipore: Annual Revenues, 2017-2022 (EUR Billion)
  • Figure 7.2 Thermo Fisher Scientific: Annual Revenues, FY 2017-FY 2022 (USD Billion)
  • Figure 8.1 Eppendorf: Annual Revenues, FY 2018-FY 2022 (EUR Million)
  • Figure 8.2 Sartorius Stedim Biotech: Annual Revenues, 2018-Q1 2023 (EUR Million)
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-Wise Trend
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 9.4 Partnerships and Collaborations: Distribution by Focus Area
  • Figure 9.5 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
  • Figure 9.6 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 9.7 Partnerships and Collaborations: Distribution by Type of Biologics Synthesized
  • Figure 9.8 Partnerships and Collaborations: Distribution by Type of Bioreactor Involved
  • Figure 9.9 Partnerships and Collaborations: Distribution by Location of Facility (Country) and Expanded Bioreactor Capacity
  • Figure 9.10 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.11 Partnerships and Collaborations: Local and International Agreements
  • Figure 9.12 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Figure 10.1 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in North America
  • Figure 10.2 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in Europe
  • Figure 10.3 Product Competitiveness Analysis: Stirred Tank Single-use Bioreactors Offered by Players in Asia-Pacific and Rest of the World
  • Figure 10.4 Product Competitiveness Analysis: Fixed-Bed Single-use Bioreactors
  • Figure 10.5 Product Competitiveness Analysis: Wave-Induced / Rocking Single-use Bioreactors
  • Figure 10.6 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in North America
  • Figure 10.7 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in Europe
  • Figure 10.8 Product Competitiveness Analysis: Other Types of Single-use Bioreactors Offered by Players in Asia-Pacific and Rest of the World
  • Figure 11.1 Brand Positioning Analysis: Competitive Advantage
  • Figure 11.2 Brand Positioning Analysis: Reasons to Believe
  • Figure 11.3 Brand Positioning Matrix: Pall Corporation
  • Figure 11.4 Brand Positioning Matrix: Biolinx Labsystems
  • Figure 11.5 Brand Positioning Matrix: Eppendorf
  • Figure 11.6 Brand Positioning Matrix: Solaris Biotech
  • Figure 11.7 Brand Positioning Matrix: Sartorius Stedim Biotech
  • Figure 11.8 Brand Positioning Matrix: Applikon Biotechnology
  • Figure 11.9 Brand Positioning Matrix: Cercell
  • Figure 12.1 Patent Analysis: Distribution by Type of Patent
  • Figure 12.2 Patent Analysis: Cumulative Year-wise Trend by Application Year, Pre-2015- 2023
  • Figure 12.3 Patent Analysis: Cumulative Year-wise Trend by Publication Year, Pre-2015- 2023
  • Figure 12.4 Patent Analysis: Distribution of Type of Patents and Publication Year, Pre-2015- 2023
  • Figure 12.5 Patent Analysis: Distribution by Patent Jurisdiction
  • Figure 12.6 Patent Analysis: Distribution by CPC Symbols and Sections
  • Figure 12.7 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
  • Figure 12.8 Leading Industry Players: Distribution by Number of Patents
  • Figure 12.9 Leading Patent Assignees: Distribution by Number of Patents
  • Figure 12.10 Patent Benchmarking Analysis: Distribution of Leading Industry Player by Patent Characteristics (CPC Codes)
  • Figure 12.11 Patent Analysis: Distribution by Patent Age
  • Figure 12.12 Single-use Bioreactors: Patent Valuation
  • Figure 13.1 Global Single-use Upstream Bioprocessing Technology Market, 2023-2035 (USD Billion)
  • Figure 13.2 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Scale of Operation, 2023-2035 (USD Billion)
  • Figure 13.3 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Type of Equipment, 2023-2035 (USD Billion)
  • Figure 13.4 Global Single-use Upstream Bioprocessing Technology Market: Distribution by Geographical Region, 2023-2035 (USD Billion)
  • Figure 13.5 Global Single-use Bioreactors Market, 2023-2035 (USD Billion)
  • Figure 13.6 Global Single-use Bioreactors Market: Distribution by Type of Bioreactor, 2023-2035 (USD Billion)
  • Figure 13.7 Global Single-use Bioreactors Market: Distribution by Scale of Operation, 2023-2035 (USD Billion)
  • Figure 13.8 Global Single-use Bioreactors Market: Distribution by Type of Cell Culture, 2023-2035 (USD Billion)
  • Figure 13.9 Global Single-use Bioreactors Market: Distribution by Type of Biologics Synthesized, 2023-2035 (USD Billion)
  • Figure 13.10 Global single-use Bioreactors Market: Distribution by Application Area, 2023-2035 (USD Billion)
  • Figure 13.11 Global single-use Bioreactors Market: Distribution by End-users, 2023-2035 (USD Billion)
  • Figure 13.12 Global Single-use Bioreactors Market: Distribution by Geographical Region, 2023-2035 (USD Billion)
  • Figure 14.1 Single-use Bioreactors Market: SWOT Analysis
  • Figure 14.2 Comparison of SWOT Factors: Harvey Ball Analysis
  • Figure 16.1 Bioprocess Control Software: Distribution by Scale of Operation
  • Figure 16.2 Bioprocess Control Software: Distribution by Key Features
  • Figure 16.3 Bioprocess Control Software: Distribution by Compatibility with System
  • Figure 16.4 Bioprocess Control Software: Distribution by Type of Process Controlled
  • Figure 16.5 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Figure 16.6 Bioprocess Control Software Developers: Distribution by Company Size
  • Figure 16.7 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Figure 16.8 Upstream Controllers: Distribution by Scale of Operation
  • Figure 16.9 Upstream Controllers: Distribution by Key Features
  • Figure 16.10 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Figure 16.11 Upstream Controllers: Distribution by Type of Bioprocess
  • Figure 16.12 Upstream Controllers: Distribution by Type of Process Controlled
  • Figure 16.13 Upstream Controller Developers: Distribution by Year of Establishment
  • Figure 16.14 Upstream Controller Developers: Distribution by Company Size
  • Figure 16.15 Upstream Controller Developers: Distribution by Location of Headquarters
  • Figure 16.16 Downstream Controller Systems: Distribution by Scale of Operation
  • Figure 16.17 Downstream Controller Systems: Distribution by Key Features
  • Figure 16.18 Downstream Controller Systems: Distribution by Type of System
  • Figure 16.19 Downstream Controller Systems: Distribution by Type of Bioprocess
  • Figure 16.20 Downstream Controller Systems: Distribution by Application Area
  • Figure 16.21 Downstream Controller System Developers: Distribution by Year of Establishment
  • Figure 16.22 Downstream Controller System Developers: Distribution by Company Size
  • Figure 16.23 Downstream Controller System Developers: Distribution by Location of Headquarters
  • Figure 17.1 Concluding Remarks: Current Market Landscape of Single-use Bioreactors
  • Figure 17.2 Concluding Remarks: Partnerships and Collaborations
  • Figure 17.3 Concluding Remarks: Patent Analysis
  • Figure 17.4 Concluding Remarks: Market Forecast and Opportunity Analysis